Danaher Schedules First Quarter 2019 Earnings Conference Call

WASHINGTON, March 19, 2019 /PRNewswire/ –Danaher Corporation (NYSE: DHR) announced today that it will webcast its quarterly earnings conference call for the first quarter 2019 on Thursday, April 18, 2019 beginning at 8:00 a.m. ET and lasting approximately 1 hour. The call and an accompanying slide presentation will be webcast on the “Investors” section of... Read more

NanoString Technologies Announces Commencement of Public Offering of Common Stock

SEATTLE, March 18, 2019 (GLOBE NEWSWIRE) — NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced an underwritten public offering of 4,500,000 shares of its common stock pursuant to its shelf registration statement. NanoString intends to offer and sell, subject to market and other conditions, 2,500,000 shares of common stock, and Clarus... Read more

Zhejiang University Joins MilliporeSigma’s CRISPR Core Partnership Program

March 14, 2019 MilliporeSigma’s global network of more than 80 CRISPR core partners promote ethical scientific exploration with genome editing via access to company’s network of experts Zhejiang University is first in China to use MilliporeSigma’s Arrayed CRISPR Library MilliporeSigma, a leading science and technology company, today announced a CRISPR core partnership with Zhejiang University... Read more

Oxford Nanopore launches Flongle, for rapid, smaller DNA/RNA sequencing tests in any environment

Tue 12th March 2019 Oxford Nanopore has today made Flongle starter packs available to purchase, after initial testing in an early-access programme.  Flongle introduces a new paradigm of smaller, on-demand DNA or RNA sequencing tests, with the potential to transform a range of applications where rapid insights are required at low cost. Oxford Nanopore’s goal is... Read more

DNAnexus Introduces Innovative Clinico-Genomic Browser to Allow Diverse Research Teams to Explore Complex Human Data Sets

The Regeneron Genetics Center successfully deployed the cohort browser against a large genomic and phenotypic UK Biobank data set March 11, 2019 09:15 AM Eastern Daylight Time MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–DNAnexus, Inc., the leader in biomedical informatics and data management, today announced the addition of an innovative browser for clinico-genomic cohorts to its DNAnexus Apollo™... Read more

Nuvec®: A breakthrough technology for mRNA / pDNA delivery for vaccines and cancer treatments

N4 Pharma Plc (AIM: N4P), a specialist pharmaceutical company, is developing Nuvec® – a unique non-viral adjuvant delivery system for vaccines and cancer treatments. This silica nanoparticle has the potential to help commercialize cancer immunotherapy drugs and improve the effectiveness of viral vaccines. Nuvec® silica nanoparticles have a unique irregular (spikey) surface structure, coupled with... Read more

Novel enzyme from LGC, Biosearch Technologies is fast and specific, even at room temperature

LGC, Biosearch Technologies proudly introduces RapiDxFire™ Thermostable RT, a truly thermostable reverse transcriptase (RT) designed specifically to meet the needs of diagnostic kit developers.   This reverse transcriptase has a temperature optimum from 55 – 80 °C, improving reaction specificity and allowing synthesis from diverse RNA templates.  It is also fast, with a reaction time of five... Read more

IDT lowers genomic barriers with powerful rhAmpSeq™ targeted sequencing system

Mar 6, 2019 CORALVILLE, IA (March 6, 2019) – As a dedicated innovator of tools and solutions for genomics applications, Integrated DNA Technologies (IDT) introduces its unique, rhAmpSeq™ targeted sequencing system – providing researchers with highly accurate, cost-effective and easy-to-use amplicon sequencing on Illumina® next-generation sequencing (NGS) platforms. The proprietary rhAmpSeq chemistry enables multiplexing at impressive levels with high on-target rates... Read more

Canopy Biosciences Announces Exclusive License for Error Corrected Sequencing Technology

M ST. LOUIS, March 5, 2019 /PRNewswire/ — Canopy Biosciences™ LLC, a leading provider of gene editing and gene expression products and services, announced today that they had exclusively licensed technology for error correction in next generation sequencing (NGS) from Washington University.  This license includes both a novel method and bioinformatic tools that combine to significantly improve... Read more